Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing burden of cardiovascular diseases
3.2.1.2 Technological advancements in annuloplasty systems
3.2.1.3 Rising demand for minimally invasive procedures
3.2.2 Industry pitfalls & challenges
3.2.2.1 Potential complications and adverse events
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Future market trends
3.7 Reimbursement scenario
3.8 Porter's analysis
3.9 PESTEL analysis
3.10 GAP analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Rigidity, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Flexible
5.3 Rigid
5.4 Semi-rigid
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Mitral valve repair
6.3 Tricuspid valve repair
6.4 Aortic valve repair
Chapter 7 Market Estimates and Forecast, By Shape, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Open
7.3 Closed
Chapter 8 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Ambulatory surgical centers
8.4 Cardiac catheterization labs
8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.2 Affluent Medical
10.3 BioStable Science & Engineering
10.4 Corcym UK Limited
10.5 Coroneo
10.6 Edwards Lifesciences Corporation
10.7 Genesee BioMedical
10.8 Medtentia International Ltd Oy
10.9 Medtronic plc
10.10 Micro Interventional Devices Incorporated
